Roivant Sciences Ltd.ROIVNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+6.1%
5Y CAGR+21.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+6.1%/yr
Annual compound
5Y CAGR
+21.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $628.11M | +14.1% |
| 2024 | $550.41M | +25.1% |
| 2023 | $439.91M | -16.2% |
| 2022 | $525.22M | +8.7% |
| 2021 | $483.04M | +104.1% |
| 2020 | $236.63M | -10.1% |
| 2019 | $263.22M | - |